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ABSTRACT 
The aim of this work was to develop and evaluate curcumin loaded liposome and its bio- enhancement. Curcumin was selected as a natural drug 
for liposome formulation. Curcumin show variety of biological activity but it also shows poor bioavailability due to low aqueous solubility (1 
µg/ml), poor absorption and rapid metabolism so that piperine was selected as bio enhancer to improve curcumin bioavailability. Soy lecithin 
and cholesterol were used to prepared curcumin and curcumin-piperine loaded liposome at different ratio by thin film hydration method 
because of easy to perform, and high encapsulation rates of lipid. The all liposome formulations (F1-F5) were evaluated by mean particle size, 
polydispersity index, zeta potential, encapsulation efficiency and drug release. Bioavailability was also determined on rat. Blood samples were 
collected at specific intervals, and plasma was separated by ultracentrifugation. Plasma was analyzed by high-performance liquid 
chromatography at 425 nm taking acetonitrile: water (75:25 v/v) acidified with 2% acetic acid as a mobile phase at a flow rate of 0.5 ml/min 
using C18 column. The mean particle size was found in the range between 800-1100 that indicate liposome are large unilamellar vesical types. 
By zeta potential study its conform that the all formulation was stable. The encapsulation efficiency of all liposome formulation are varied 
between 59-67%. In vitro drug release was analyse in 7.4 pH phosphate buffer, the maximum %CDR observed at the 12 hrs., and formulation 
are follow sustained release thus they reduce metabolism, good absorption rate which improve bioavailability of  drug. From in-vivo study, it is 
clear that curcumin-piperine liposomal formulation, increases Cmax, area under the curve, and mean residence time significantly as compared 
to pure curcumin and pure curcumin liposome. 
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1. INTRODUCTION: 
Turmeric are a one of most popular pant that contains 
various medical properties. Turmeric is also known as 
“Indian saffron.” Modern medicine has begun to recognize its 
importance, as indicated by the over 3000 publications 
dealing with turmeric that came out within the last 25 years. 
It is very popular in spices category as a food product 
Directorate of Canada, and joint Expert Committee of the 
food and agriculture organization/World health 
Organization (FAO/WHO) (1, 2). 
Curcumin (Diferuloylmethane) are the main constituent of 
spices turmeric and is obtain from the rhizome of the East 
Indian plant Curcuma longa, family- Zingiberacae. It is one 
on the most promising natural products for both the 
biological and chemical study (3). Polyphenols have capacity 
to prevent and treatment of various disease due to their 
antioxidant capabilities (4). Polyphenols are derived from 
many components of the human food like turmeric. 
Curcumin has not only food derivatives it also shown 
multiple beneficial medicine properties to prevent the 
disease (5). 
Curcumin belong to Curcuminoids group, which are 
hydrophobic, low molecular weight polyphenol responsible 
for yellow color of turmeric (6, 7). Curcumin having various 
functional group, the aromatic ring (phenol) are connected 
with two α, β-unsaturated carbonyl groups. Molecular 
configuration of curcumin can exist in bis-keto and enolate 
of tautomeric forms (8, 9, 10).  
 
Fig. 1: Structure of curcumin 
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Many researches has been proven that, the reasons for poor 
bioavailability of any drug are correlated to poor absorption, 
high rate of metabolism, rapid elimination and clearance 
from the body. The only one major drawback of curcumin is 
poor oral bioavailability due to low aqueous solubility (1 
µg/ml), poor absorption and rapid metabolism.  When the 
curcumin is taken orally only small portion is absorbed 
within the intestine and this absorbed curcumin has rapid 
metabolism in the liver and plasma and major portion is 
excreted through the faces and urine by converted to 
glucuronides and sulfates (water-soluble) metabolites 
(11,12,13,14,15). 
In this case some of the possible ways to overcome these 
problems, Adjutants which can block metabolic pathways of 
curcumin, are one of the major means that are being used to 
improve its bioavailability. Nanoparticles, liposomes, 
micelles, and phospholipid complexes are other promising 
novel formulations, which appear to provide longer 
circulation, better permeability, and resistance to metabolic 
processes (12). 
2. MATERIALS AND METHODS: 
Soy lecithin was purchased from Hi Media Laboratories Pvt. 
Ltd, Mumbai, India. Cholesterol, Methanol, Petroleum 
ether,Glacial acetic acid and Sodium chloridewas purchased 
from Loba Chemie Pvt. Ltd, Mumbai, India. Curcumin and 
Piperine was purchased from Alfa Aesar, Hyderabad, India. 
Chloroform, Acetic acid HPLC grade, Acetonitrile HPLC grade 
and Water for HPLCwas purchased from Merck life Science 
Private Ltd., Mumbai, India.Potassium di hydrogen 
phosphatewas purchased from Molychem, Mumbai, India. 
Preformulation Studies  
Physical appearance: 
Physical appearance of any substance was analyzed on the 
bases of size, shape and appearance by visually inspection 
and compare with standard. The usual appearance of 
curcumin and piperine was deals with Indian pharmacopeia 
standard (16). 
Melting point: 
The melting point of curcumin and piperine was determine 
by using digital melting point apparatus (Rolex, Haryana) by 
taken a small amount of drug in capillary tube closed by one 
side and placed in the apparatus. Then noted the 
temperature at which drug sample get completely melted 
and disappeared (17).   
Solubility study: 
The solubility of curcumin and piperine was determine by 
taking a fixed and small amount of solute with added fixed 
amount of solvent in a test tube, after addition of solvent test 
tube was vigorously shaken for dissolve solute particles. The 
solubility of the curcumin was tested in various solvents 
including water, methanol, chloroform, petroleum ether, 
glacial acetic acid, acetic acid, ethanol etc. The solubility was 
observed only by the visual inspection (18, 19). 
 
Compatibility test by FT-IR spectral studies: 
Compatibility test was performed by Fourier Transform 
Infrared Spectrophotometer (FTIR). For the FT-IR 
(Shimadzu, Japan) study first blank disc was prepared with 
potassium bromide (KBr) which placed in the path of the 
reference beam. Scanned it at the scanning range between 
4000 cm-1 and 450 cm-1, resolution was 1 cm-1 and then 
analysis pure drug and drug-excipient (physical mixture) 
was taken and drying properly to remove moisture and 
grounded with potassium bromide (KBr) (1:1000 ratio) then 
placed in sample holder. Obtained peak were interpreted by 
functional group if any change in peak of functional group as 
compared to pure drug peak will indicate that interaction of 
drug-excipient or drug-polymer (20, 21). 
Determination of λmax: 
UV spectrophotometer (Shimadzu-1800, Japan) was used to 
determine the maximum absorption (λmax) of drug.  Stock 
solution of Curcumin and piperine was prepared in 
methanol solvent, the solution has containing 2 µg/ml were 
scanned separately in the range between 300-500 nm to 
determine the wavelength of maximum absorption of drug 
(22, 23). 
Development of calibration curve 
Calibration curve of curcumin and piperine was developed 
by UV-visible spectrophotometer. 
Preparation of stock solution: 
A stock solution of curcumin and piperine was prepared by 
dissolving 50mg of drug in 50ml of methanol in volumetric 
flask to obtain a concentration of 1mg/ml. Selection of 
solvent system was based on the solubility and stability of 
drug in solvent. 5 ml of this solution was further diluted with 
50ml of same solvent (methanol) to get the final 
concentration of 100 µg /ml and this was used as the 
standard stock solution. 
Preparation of calibration curve: 
From this stock solution various dilutions were made to 
obtain of 1, 2, 3, 4, 5, and 6µg/ml concentration in 
volumetric flak in a same solvent. And then absorbance 
values of these solutions were measure at lambda max 
425nm (24, 25) 
Preparation of liposome: 
Curcumin and curcumin-piperine loaded liposomes were 
prepared by the thin film hydration method. Required 
amount of drug (200mg), soy lecithin (500mg), and 
cholesterol (500mg) were dissolve in methanol: chloroform 
solvent (1:9), the dried ingredient was dissolve in solvent by 
hand shaking method in round bottom flask. And solution 
was dried by hand shaking to form a thin film of lipid. The 
flask was kept overnight for complete evaporation of organic 
solvents. Then the dried layer was hydrated with 30 ml of 
distilled water and vortexed for 1 hours. After hydration 
liposomal suspension was formed. Finally, the product 
obtained is collected and stored in a sealed container at 2-
8˚C until analysis (26). 
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Table 1: Formulation table 
S.No. Ingredient Quantity 
Formulation cord 
F1 F2 F3 F4 F5 
1 Curcumin(mg) 200     
2 Curcumin: Piperine (mg) (w/w)  (5:1) 200 (10:1)     200 (15:1) 200 (20:1) 200 
3 Soy Lecithin (mg) 500 500 500 500 500 
4 Cholesterol (mg) 500 500 500 500 500 
5 Methanol : Chloroform (v/v) 1:9 q.s. 1:9 q.s. 1:9 q.s. 1:9 q.s. 1:9 q.s. 
6 Distilled water 30 ml 30 ml 30 ml 30 ml 30 ml 
 
Evaluation/characterization of formulated liposome 
Particle size and polydispersity index estimation: 
Mean particle size and polydispersity index of prepared 
liposomes were estimated using Zetasizer 300HSA (Malvern 
instrument, Malvern, UK). The sample are diluted with 
distilled water and analyzed at 25°C using quartz micro 
cuvette then run the instrument and estimated the particle 
size and polydispersity index (27, 29). 
Zeta potential: 
Zeta potential was analyze by using Zetasizer. The 
formulations were diluted to 1:1000 with the aqueous phase 
of the formulation to get a suitable kilo counts per second 
(kcps). Analysis was carried out at 25°C with an angle of 
detection of 90° (27, 28). 
Drug encapsulation efficiency: 
The percentage drug entrapped (PDE) in the Curcumin and 
curcumin-piperine loaded liposomes was determined by the 
ultra-centrifugation at 11000-15000 rpm for 45 min in an 
ultracentrifuge to septet the loaded drug from free drug. 
Then, supernatant was separated and analyzed after suitable 
dilution in solvent by UV-Visible spectrophotometer at 
425nm, which is indicates the amount of free drug. The 
liposome(sediment) was redispersed in same solvent 
(methanol) and analyzed drug content after dilution using 
UV-visible spectrophotometer, which is indicate the amount 
of drug entrapped (30,31). 
The entrapment efficiency of liposome was calculated by this 
equation 
DEE= [(T-C)/T] ×100 
Where,  
T = total amount of drug that is detected both in the 
supernatant and sediment,  
C = amount of drug detected only in the supernatant. 
In vitro drug release studies: 
In vitro drug release was performed using dialysis 
membrane method. Firstly, membrane was clamped in open 
glass tube for drug release and consider as a donor 
compartment.7.4 pH Phosphate buffer solution (PBS) 200ml 
was used as dissolution medium and taken in receiver 
compartment.  
The glass tube (donor compartment) edge was just touched 
in receiver compartment. Before the release test, 0.5 ml of 
formulation was diluted with 3ml of dissolution medium and 
placed into glass tube and maintains the temperature 37˚C at 
100 rpm by magnetic stirrer and bead. 5 ml sample was 
withdrawing from receiver compartment at fixed intervals 
and maintain the sink condition by replaced with fresh 
medium immediately. Sample were analyzed using UV-
Visible Spectrophotometer at 425nm. Drug release was 
checked for 12 hrs. (32). 
In vivo drug release (Pharmacokinetic study for 
determination of Curcumin): 
In vivo study was perform in Sprague-Dawley rat. All the 
animal experiments were performed according to the rules 
and guidelines of the committee for the purpose of control 
and supervisions of experiments on animals (CPCSEA). This 
study was approved by Institutional Animal Ethical 
committee Regd.No.1321/PO/ReBi/S/10/CPCSEA, Date-
22/10/014, Approval No. CIP/IAEC/2017/099 (33). 
Construction of Curcumin standard graph: 
A standard graph of Curcumin was developed for the 
assessment of pharmacokinetics of the Curcumin 
formulations in rat by the following method. 100 mg of pure 
Curcumin was dissolved in 100 ml of methanol and 
sonicated for 10 min to prepare stock solution. 10 ml stock 
solution was taken and diluted with the same solvent, i.e., 
methanol up to 100 ml and again sonicated to form standard 
solution. From standard solution, further dilution was 
prepared, viz., 0.2 ml was transferred from the standard 
solution into test tubes and diluted to 10 ml with methanol 
to form 2 µg/ml. The solutions so prepared (2, 4, 6, 8, and 10 
µg/ml). The samples were analyzed in HPLC at 425 nm 
taking acetonitrile: water (75:25 v/v) acidified with 2% 
acetic acid as a mobile phase at a flow rate of 0.5 ml/min 
using C18 column (31). The retention time and peak area 
were noted and data obtained through HPLC analysis was 
further used to interpolate, the experimental peak area 
values to get the corresponding concentration of Curcumin 
in plasma. 
Procedure: 
1. Selection of experimental animal 
2. Grouping of animal 
3. Administration of formulation into animal 
4. Collection of blood sample 
5. Determination of drug sample in animal by HPLC method 
and determination of pharmacokinetic parameter such 
as - Cmax, Tmax, AUC, MRT, Kel 
Animals were divided into four groups; each group 
contains six rats: 
Group 1 received: Liposomal Curcumin 
Group 2 received: Liposomal Curcumin + pure piperine 
Group 3 received: Liposomal Curcumin: Piperine 
formulation 
Group 4 (standard) received: Pure Curcumin. 
Blood samples (0.5 ml) from the experimental rats were 
collected by retro-orbital plexus technique into a sequence 
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of micro centrifuge tubes containing 0.3 ml of sodium citrate 
solution. Blood samples were taken at different time 
intervals such as 30 min, 1, 2, 3, 6, 12, 18, and 24 h. The 
collected blood samples were centrifuged at a speed of 5000 
rpm for 10 min, and plasma was separated into an additional 
micro centrifuge tube using micropipette and stored in deep 
freeze until analysis. The drug was extracted out from 
plasma by adding in a methanolic solvent, and it was 
centrifuged for 10 min from which the organic layer of drug 
comes out other than sediment. The organic layer of drug 
was then injected into the HPLC system for the further 
processing of determination of plasma drug concentration 
and other parameters, i.e., area under the curve (AUC), 
Cmax, etc. and report the bioavailability enhancement of 
curcumin (34,35,36,37).  
 
3. RESULTS    
Preformulation studies 
Physical appearance: 
Physical appearance of Curcumin and piperine was deals 
with IP. Curcumin was found to be bright yellow orange 
amorphous powder and piperine was found to be pale 
yellow crystal. 
Determination of melting point: 
Melting point of Curcumin was found to be in range between 
180-183 ˚C and piperine was found to be 130 ˚C which 
compiles with Indian pharmacopoeia specification so it was 
confirmed that the sample which purchased for liposome 
was Curcumin and piperine. The melting data show in table 
2. 
 
Table 2: Melting point of Curcumin and piperine 
S.No. Drug Melting point (Theoretical) Average melting point(practically) 
1 Curcumin 183˚C 181 ˚C 
2 Piperine 130˚C 129˚C 
 
Solubility analysis: 
The solubility of pure drug sample of Curcumin and piperine was analyzed with various solvent and result was found to be: 
Table 3: Solubility test of Curcumin and piperine 
S.No. Solvent Curcumin Piperine 
1 Water Insoluble Insoluble 
2 Methanol Soluble Soluble 
3 Chloroform Soluble Soluble 
4 Petroleum ether Insoluble Soluble 
6 Acetic acid Soluble Soluble 
7 Ethanol Soluble Soluble 
 
Identification test and compatibility test by FTIR 
spectrophotometer: 
The sample of Curcumin and piperine was identified by FTIR 
spectra. The FTIR spectrum of pure drug and physical 
mixture show the characteristic absorption with functional 
group. By this study confirm the compatibility of Curcumin 
with excipients.  
Characteristic peaks obtained are shown: 
 
 
Fig. 2: FT-IR of pure Curcumin 
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Fig. 3: FT-IR of pure piperine 
 
Fig. 4: FT-IR of pure Curcumin and piperine 
 
Fig. 5: FT-IR of Curcumin liposome 
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Fig. 6: FT-IR of Curcumin piperine liposome 
 
Table 4: Characteristic peak of Curcumin 
S.No. Functional group Theoretical peak (cm-1) Practical peak (cm-1) 
1 Phenolic –OH 3406.54 3401.21 
2 -C=O 1631.08, 1604.78 1629.93, 1603.85 
3 Aromatic –C=O 1431.03 1428.25 
 
Table 5: Characteristic peak of piperine 
S.No. Functional group Theoretical peak (cm-1) Practical peak (cm-1) 
1 Symmetric and asymmetric stretching of C=C (diene) 1635; 1608 1633; 1604.52 
2 Aromatic stretching of C=C (benzene ring) 1608; 1580 1601; 1601.25 
3 Stretching of –CO-N 1635 1632.58 
4 Asymmetric and symmetric, aliphatic C-H stretching 2925; 2840 2926; 2844.32 
5 CH2 bending 1450 1451.59 
6 Asymmetrical stretching =C-O-C 1250; 1190 1249; 1193.57 
7 C-O stretching 930 931.22 
8 
Out-of-plan C-H bending 1,2,4- trisubstitited phenyl 
(two adjacent hydrogen atoms) 
850; 830; 805 847; 829.31; 801.68 
 
Table 6: Characteristic peak of mixture of pure Curcumin and piperine 
S.No. Functional group Theoretical peak (cm-1) Practical peak (cm-1) 
1 Phenolic –OH 3406.54 3401.21 
2 Symmetric and asymmetric stretching of C=C (Diane) 1635; 1608 1633; 1604.52 
3 -C=O 1631.08, 1604.78 1629.93, 1603.85 
4 Aromatic stretching of C=C (benzene ring) 1608; 1580 1601; 1601.25 
5 Aromatic –C=O 1431.03 1428.25 
6 Stretching of –CO-N 1635 1632.58 
7 Asymmetric and symmetric, aliphatic C-H stretching 2925; 2840 2926; 2844.32 
8 Asymmetrical stretching =C-O-C 1250; 1190 1249; 1193.57 
9 C-O stretching  930 931.22 
10 Out-of-plan C-H bending 1,2,4- trisubstitited phenyl 
(two adjacent hydrogen atoms) 
850; 830; 805 847; 829.31; 801.68 
 
Table 7: Characteristic peak of Curcumin liposome 
S.No. Functional group Theoretical peak (cm-1) Practical peak (cm-1) 
1 Phenolic –OH 3406.54 3401.21 
2 -C=O 1631.08, 1604.78 1629.93, 1603.85 
3 Aromatic -C=O 1431.03 1428.25 
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Table 8: Characteristic peak of mixture of Curcumin piperine liposome 
S.No. Functional group Theoretical peak (cm-
1) 
Practical peak (cm-1) 
1 Phenolic –OH 3406.54 3401.21 
2 Symmetric and asymmetric stretching of C=C 
(diene) 
1635; 1608 1633; 1604.52 
3 -C=O 1631.08, 1604.78 1629.93, 1603.85 
4 Aromatic stretching of C=C (benzene ring) 1608; 1580 1601; 1601.25 
5 Aromatic -C=O 1431.03 1428.25 
6 Stretching of –CO-N 1635 1632.58 
7 Asymmetric and symmetric, aliphatic C-H stretching 2925; 2840 2926; 2844.32 
8 Asymmetrical stretching =C-O-C 1250; 1190 1249; 1193.57 
9 C-O stretching  930 931.22 
10 Out-of-plan C-H bending 1,2,4- trisubstitited phenyl 
(two adjacent hydrogen atoms) 
850; 830; 805 847; 829.31; 801.68 
 
λmax analysis: 
The absorption spectrum of pure drug was scanned in 200-
800 nm. The lambda max of pure Curcumin was found to be 
425 nm which is standard range between i.e., 421-425 nm 
and piperine was found to be 342 nm it is range between 
341-343nm.The λmax analysis data show in table 9.
 
Table 9: Wavelength of maximum absorption of Curcumin and piperine 
S.No. Drug Theoretical λmax Practically Obtain λmax 
1 Curcumin 421-425 nm 425 nm 
2 Piperine 342 nm 342 nm 
 
 
Fig. 7: Lambda max of Curcumin 
 
Fig. 8: Lambda max of piperine 
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Calibration curve of Curcumin and piperine: 
Standard calibration curve in Table no.10 and 11 show the 
absorbance of Curcumin and piperine at different 
concentration 1, 2, 3 4, 5, and 6 µg/ml and figure no. 9 and 
10 show the standard curve of Curcumin at 425nm and 
piperine at 342 nm. The regression value was found to be 
0.9953 and 0.996. 
Table 10: Absorbance of Curcumin at different 
concentration 
S.No. Concentration 
(µg/ml) 
Absorbance of Curcumin 
(425 nm) 
1 1 µg/ml 0.274 
2 2 µg/ml 0.419 
3 3 µg/ml 0.582 
4 4 µg/ml 0.800 
5 5 µg/ml 0.938 
6 6 µg/ml 1.163 
 
 
Fig. 9: Standard calibration curve of Curcumin 
 
Table 11 Absorbance of piperine at different 
concentration 
S.No. Concentration 
(µg/ml) 
Absorbance of piperine 
(342 nm) 
1 1 µg/ml 0.140 
2 2 µg/ml 0.274 
3 3 µg/ml 0.389 
4 4 µg/ml 0.565 
5 5 µg/ml 0.664 
6 6 µg/ml 0.834 
 
 
Fig. 10: Standard calibration curve of piperine 
 
Evaluation of final formulation 
Mean particle size and Polydispersity Index: 
Mean particle size of all liposome formulation (F1-F5) is 
found in range between 800-1000. By the result obtain of 
mean particle size it can conclude that the all liposomes are 
a large unilamellarvesicle types liposome. PDI and Mean 
particle size data show in table 12 and figure 11-15. 
 
Table 12: Mean Particle Size and Polydispersity Index of all liposome formulation 
Formulation code Mean particle size (nm) Polydispersity Index 
F1 819.5 0.841 
F2 1031 0.855 
F3 1081 1 
F4 848 0.858 
F5 931 0.909 
 
 
Fig. 11: Graph of mean particle size and polydispersity index (F1) 
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Fig. 12: Graph of mean particle size and polydispersity index (F2) 
 
 
Fig. 13: Graph of mean particle size and polydispersity index (F3) 
 
Fig. 14: Graph of mean particle size and polydispersity index (F4) 
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Fig. 15: Graph of mean particle size and polydispersity index (F5) 
 
Zeta potential: 
The stability of liposome is directly related to the charge 
present in mobile surface, which is termed as zeta potential. 
Zeta potential was determining by the zetasizer. The zeta 
potential of liposomes formulation F1-F5 was found in range 
between -1 to -29 mV. By zeta potential study its conform 
that the all formulation was stable. Surface charge data show 
in table 13: 
Table 13: Zeta potential of liposome formulation 
Formulation code Zeta potential (mV) 
F1 -1.18±1.6 
F2 -9.73±25 
F3 -17.10±90 
F4 -21.32±5.8 
F5 -29.6±6.0 
 
Drug encapsulation efficiency: 
The result of encapsulation efficiency of all formulation was 
found to be almost similar. Also it can be observed that, 
encapsulation efficiency was increase with increasing 
particle size. Table 14 and figure 16 was shown the drug 
encapsulation efficiency of liposome. 
 
Table 14: Drug encapsulation efficiency of liposome 
formulation 
Drug Formulations Encapsulation efficiency 
(%) 
1 F1 59% 
2 F2 65% 
3 F3 67% 
4 F4 61% 
5 F5 63% 
 
 
Fig. 16: Graph of drug encapsulation efficiency of 
liposome formulation 
In-vitro drug release studies: 
In-vitro drug release of Curcumin liposome and curcumin-
piperine liposome formulation was carried out by using 
dialysis membrane in 7.4 pH phosphate buffer for 12 hrs. 
and drug release varied in range between 70-77%, and all 
formulation are follow sustained release thus they reduce 
metabolism, good absorption rate which improve 
bioavailability of drug. The good cumulative drug release 
existed in all batches. After application of data treatment to 
dissolution, release behavior follows zero order kinetic. In 
vitro drug release profile data show in table 15 and 16 and 
figure 17. 
 
Fig. 17 In vitro drug release profile of liposome 
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Table 15: Percentage cumulative drug release profile of liposome formulation 
S.No. Time (hr.) %CDR 
F1 F2 F3 F4 F5 
1 0.5 25.85 26.23 26.60 25.55 25.88 
2 1 27.01 27.29 27.67 26.59 27.52 
3 1.5 27.94 28.19 29.02 27.68 28.29 
4 2 29.18 29.43 30.35 28.95 30.35 
5 3 30.47 30.79 32.75 30.61 32.44 
6 4 31.57 31.79 34.11 31.64 33.79 
7 6 34.67 35.05 43.56 37.12 42.70 
8 8 44.12 46.74 63.50 48.12 53.90 
9 10 64.06 68.07 72.23 68.09 68.63 
10 12 70.96 71.28 77.24 71.30 73.47 
 
Table 16: Best Fit Model for all formulations 
Formulations Zero order First order Higuchi 
matrix 
Peppas plot Best fit Model 
R2 R2 R2 R2 
F1 0.9078 0.7441 0.8062 0.7362 Zero order 
F2 0.9083 0.7519 0.8105 0.7361 Zero order 
F3 0.964 0.8486 0.8973 0.8226 Zero order 
F4 0.9326 0.7809 0.8425 0.7745 Zero order 
F5 0.9726 0.8409 0.9013 0.8374 Zero order 
 
In vivo study: 
In vivo bioavailability study demonstrated the signification improvement of curcumin-piperine loaded liposome as compared to 
pure Curcumin. Liposome Curcumin and liposome Curcumin-pure piperine formulation were show increased bioavailability 
but not as much as curcumin-piperine liposome formulation has presented.  
(a) (b) 
(c)                  (d) 
(e) 
Fig. 18: Standard calibration curve of Curcumin by HPLC at different concentration 2(a), 4(b), 6(c), 8(d), 10µm/ml (e) 
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Table 17: Absorbance of Curcumin at different 
concentration by HPLC 
S.No. Concentration (µg/ml) Peak area value 
1 2 µg/ml 177.133 
2 4 µg/ml 353.2281 
3 6 µg/ml 488.4909 
4 8 µg/ml 673.9156 
5 10 µg/ml 860.4714 
 
 
Fig. 19: Standard graph of Curcumin by HPLC
 
Table 18: Pharmacokinetic parameters 
Parameters Curcumin 
liposome 
formulation 
Curcumin liposome 
+ pure piperine 
Curcumin: piperine 
liposome 
Pure 
Curcumin 
Cmax (µg/ml) 3.450 10.342 15.096 1.861 
Tmax(h) 6 6 6.6 3 
AUC0-24 (µg/ml/h) 30.096 70.325 200.145 29.123 
MRT 13.46 15.22 19.221 13.01 
Kel 0.0725 0.0652 0.0325 0.0733 
 
4. CONCLUSION: 
In the present study, an attempt has been made to develop 
liposomal delivery system for Curcumin. This study indicates 
successfully preparation of Curcumin loaded liposome by 
the thin film hydration method. Preformulation studies were 
performed for identification of drug i.e. physical appearance, 
melting point, solubility study etc. which deals with the I.P. 
FT-IR study confirm the compatibility of Curcumin with 
excipients which is used in liposome preparation. 
Phospholipids i.e. soy lecithin, cholesterol used as a carrier 
for preparation of Curcumin and piperine at different ratio 
(F1-F5) by thin film hydration method. The all liposome 
formulations (F1-F5) were evaluated for mean particle size, 
polydispersity index, zeta potential, encapsulation efficiency 
and drug release. Bioavailability was also determined on rat. 
The mean particle size was found in the range between 800-
1100 that indicate liposome are large unilamellar vesicle. By 
zeta potential study it was confirmed that the all formulation 
were stable. The encapsulation efficiency of all liposome 
formulation are varied between 59-67%. In vitro drug 
release was analyze in 7.4pH phosphate buffer, the 
maximum %CDR observed at the 12 hrs. and drug release 
varied in range between 70-77%, and formulation are follow 
sustained release thus they reduce metabolism, good 
absorption rate which improve bioavailability of drug. The 
good CDR existed in all batches. After application of data 
treatment to dissolution, release behavior follows zero order 
kinetic. Curcumin-piperine ratio (10:1, F3) is selected as 
optimize formulation based on the highest entrapment 
efficiency (67%), % CDR (77.24%), particle size (1081), 
polydispersity index (1) and zeta potential (-17.10). 
Dissolution profile and In vivo bioavailability study 
demonstrated the signification improvement of curcumin-
piperine loaded liposome as compared to pure Curcumin. 
Liposome Curcumin and liposome containing curcumin-
piperine formulation were show increased bioavailability 
but not as much as curcumin-piperine liposome formulation 
had shown. Based on the observations, it can be concluded 
that the drug delivery system of Curcumin and curcumin-
piperine liposome has increase absorption and reduce 
metabolism in biological system which can improve 
bioavailability of drug. 
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